AME Publishing Company

Microphysiological Systems Conference 2023: A Deep Dive into Technologies & Applications - Innovations in 3D-Culture, Organoids, and Organs-on-Chips fields (Orlando, Florida - July 26-27, 2023) - ResearchAndMarkets.com

Retrieved on: 
Monday, June 19, 2023
Health, Biotechnology, Central Florida, City University of Hong Kong, La Jolla Institute for Immunology, University, Impact, Engineering, Organoid, Associate professor, University of Florida, Electrical engineering, AME Publishing Company, MPS, Organ (biology), Royal Army Medical Corps, Novo Nordisk, University of Central Florida, Integration, Cornell University, Conference, City University, 3D printing, Management, Medical imaging, Chemistry

The "Microphysiological Systems 2023: A Deep Dive into Technologies & Applications" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Microphysiological Systems 2023: A Deep Dive into Technologies & Applications" conference has been added to ResearchAndMarkets.com's offering.
  • The host is honored that Professor Mike Shuler, Samuel B. Eckert Professor of Engineering at Cornell University and President of Hesperos will be Chairperson of this Conference.
  • Conference Attendees Receive Full Access to the Co-Located EV Conference for Maximal Networking and Scientific Exchange.
  • **The Conference Features Scientific Presentations from Academics, Technical Presentations from Industry, Technology Spotlight Presentations from Technology-Tools Vendors, and an Exhibit Hall with Companies Showcasing their Commercial Offerings.

BIO 300 Enhances Radiotherapy Efficacy Against Lung Tumors in a Nonclinical Model

Retrieved on: 
Wednesday, May 24, 2023
Men, General Health, Science, Family, Consumer, Clinical Trials, COVID-19, Health, Other Science, Research, Other Health, Other Consumer, Radiology, Women, Pharmaceutical, Seniors, Oncology, BIO, AME Publishing Company, Radiation, Neoplasm, Lung, Policy, Clinical trial, Cancer, Lung cancer, Henry Ford Health, Quality of life, Humanetics, Lung tumor, Patient, Risk, Collateral damage, Medical imaging

The positive results showcased that BIO 300 can protect normal tissues from collateral damage associated with radiotherapy without protecting the lung tumor, while potentially sensitizing the tumors to radiotherapy.

Key Points: 
  • The positive results showcased that BIO 300 can protect normal tissues from collateral damage associated with radiotherapy without protecting the lung tumor, while potentially sensitizing the tumors to radiotherapy.
  • The studies compared the effect of radiotherapy, with and without BIO 300 dosing, on normal tissue and tumors.
  • The researchers concluded that BIO 300 was radioprotective of normal lung tissue without compromising the efficacy of radiotherapy on lung tumors.
  • The drug appeared to sensitize lung tumors to radiotherapy, suggesting a role in enhancing the therapeutic efficacy of radiotherapy.

Xiamen ITG Group Reports Financial Results for Fiscal 2022

Retrieved on: 
Friday, April 21, 2023
Parent, AME Publishing Company, Supply, Supply chain management, Multimedia, YOY, Holding company

XIAMEN, China, April 21, 2023 /PRNewswire/ -- Xiamen ITG Group Corp., Ltd (shorted for "Xiamen ITG Group".

Key Points: 
  • XIAMEN, China, April 21, 2023 /PRNewswire/ -- Xiamen ITG Group Corp., Ltd (shorted for "Xiamen ITG Group".
  • Stock Code: SH.600755)  is a state-owned  listed company, focusing on Supply Chain Management and expanding the emerging Health Technology sector.
  • We delivered a solid financial performance despite an adverse operating environment in 2022.
  • Xiamen ITG Group has been listed among the Forbes Global 2000 for six years, ranking 1418th in 2022.

Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook

Retrieved on: 
Friday, January 27, 2023
Health, Technology, Hospitals, Health Technology, Software, Clinical Trials, Biotechnology, Software as a service, NZXT, Know Labs, Jarden, Erickson, Data science, SVP, Technical, AME Publishing Company, Marketing, NYSE, Dropbox, Science, Artificial intelligence, Vista Outdoor, Research, Gaming, Trautwein, FDA, Growth, Chief commercial officer, Intellectual property, Rivian, Data collection, Medical device, Management, Oura

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced changes to its executive leadership team.

Key Points: 
  • Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced changes to its executive leadership team.
  • As announced, Ron Erickson, Founder and Chairman at Know Labs, was unanimously named Chief Executive Officer by the Company’s Board of Directors.
  • Alongside Erickson, Dr. James Anderson continues as Know Labs’ Chief Medical Officer, leading all activities related to clinical development.
  • Three changes are being implemented in the executive leadership team:
    Masanori King Takee was promoted to Chief Technology Officer.

WAYCEN, the first medical AI company to win 4 CES 2023 innovation awards "Proved K-Medtech"

Retrieved on: 
Thursday, January 5, 2023
Lung cancer, AME Publishing Company, Electronics, Research, Record, Artificial intelligence, CES, Smartphone, Odyssey Software (Mobile Device Management), Respiratory system, Deep learning, Digital, Metastasis, SCIE, Endo, Exhibition, Cough, CTA, Severance Hospital, AI, Software, Consumer Technology Association, Gangneung Asan Hospital, EBUS, Lymph, National Association Medical Staff Services, Engineering, Human, Endoscopy, Diagnosis, Medical device, Medical imaging, Industrial design

Company specialized in AI Medtech, WAYCEN, won CES innovation awards for two years in a row

Key Points: 
  • Company specialized in AI Medtech, WAYCEN, won CES innovation awards for two years in a row
    WAYCEN swept CES 2023 innovation awards with medical AI products, collaborated with the medical staff
    SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- The company specialized in AI Medtech, WAYCEN (CEO Kyungnam Kim) made splendid achievements of winning four CES innovation awards for the first time among medical AI companies ahead of 'CES 2023', the world's largest electronics exhibition, which will be held in Las Vegas, United States, in next January.
  • Winning two awards solely for the products utilizing the real-time image analysis technology is to highlight innovations in WAYCEN's medical AI solution lineup.
  • It speaks volumes within the medical industry that medical professionals and AI-specialized company jointly developed clinically useful products through technical verifications and accomplished such great performance.
  • Also, it is the AI medtech-specialized company that was selected as the "Country Representative Innovation Company 1000'" and "MEDTECH INNOVATOR APAC TOP 4".

Angélica Fuentes Joins Koning Board of Directors

Retrieved on: 
Monday, December 19, 2022
Organization, Gender representation on corporate boards of directors, Patient, Woman, APEC, Neoplasm, Breast, Health, Diagnosis, AME Publishing Company, Global health, Multimedia, Corporation, Economic Cooperation Organization, KBCT, Investment, Mexican Americans, Drug, Management, Medical imaging

NORCROSS, Ga., Dec. 19, 2022 /PRNewswire/ -- Koning Corporation has announced the addition of Angélica Fuentes to their Board of Directors.

Key Points: 
  • NORCROSS, Ga., Dec. 19, 2022 /PRNewswire/ -- Koning Corporation has announced the addition of Angélica Fuentes to their Board of Directors.
  • Angélica Fuentes is a Mexican American businesswoman and investor recognized by Forbes Magazine as one of Mexico's most powerful women.
  • Koning Corporation announces the addition of Latina businesswoman, Angélica Fuentes, to their Board of Directors.
  • Koning has quickly been filling its 2023 pipeline, and with the addition of Angélica to the board, the company is primed to expand quickly across the country.

Koning Corporation taps high-profile radiologists and researchers to join Scientific Advisory Board

Retrieved on: 
Monday, December 12, 2022
Radboud University Nijmegen, Physician, Columbia University, Feedback, Breast, WOW, Diagnosis, MRI, Radiology, United States Air Force Scientific Advisory Board, Patient, Science, Nuclear medicine, Woman, University of Maryland, College Park, Multimedia, University, AME Publishing Company, Global health, KBCT, Medical imaging, Koning

NORCROSS, Ga., Dec. 12, 2022 /PRNewswire/ -- Koning is announcing the creation of a Scientific Advisory Board, adding several high-profile radiologists and researchers to its ranks.

Key Points: 
  • NORCROSS, Ga., Dec. 12, 2022 /PRNewswire/ -- Koning is announcing the creation of a Scientific Advisory Board, adding several high-profile radiologists and researchers to its ranks.
  • Dr. Ioannis Sechopoulos (Professor of Radiology and Nuclear Medicine at Radboud University) has also joined the Scientific Advisory Board, and is an internationally recognized specialist in the science of breast CT.
  • "The creation of the Scientific Advisory Board is a sign of Koning's devotion to continually improving the performance of its Koning Vera Breast CT device," says Koning President, David Georges.
  • About Koning: Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Breast CT (KBCT).

NexGen Biobanking Opens in Gwinnett County, Bringing Crucial Biospecimen Storage Infrastructure to Georgia’s Life Science Industry

Retrieved on: 
Tuesday, November 29, 2022
Health Technology, State, Local, Technology, University, Education, General Health, Medical Devices, Public Policy, Government, Other Technology, Science, Biotechnology, Other Science, Health, Research, Medical Supplies, Growth, Global Health, CDC, Ecosystem, Private sector, Georgia Power, Global health, NexGen, Morehouse School of Medicine, Stringfellow, State of Georgia Building, Emory University, Georgia Research Alliance, AME Publishing Company, Precision medicine, Commerce, Georgia Board of Regents, Pharmaceutical industry, Transwestern

"The Center for Global Health Innovation (CGHI) is thrilled to announce and welcome NexGen Biobanking to Georgia's fast-growing life science community," said Edie Stringfellow, Vice President of Ecosystem Development at the Center for Global Health Innovation.

Key Points: 
  • "The Center for Global Health Innovation (CGHI) is thrilled to announce and welcome NexGen Biobanking to Georgia's fast-growing life science community," said Edie Stringfellow, Vice President of Ecosystem Development at the Center for Global Health Innovation.
  • Andrew Pazahanick, the Managing Partner of NexGen Biobanking, said, "We are excited about the opportunities for NexGen in the Atlanta area, Georgia, and the Southeast.
  • Georgias life sciences industry has experienced strong and steady growth in recent years, outpacing even the rapidly expanding national industry.
  • About NexGen Biobanking: NexGen Biobanking provides biorepository services for storing, preserving, managing, and guardianship of biospecimens and expeditiously provides biospecimens to researchers.

TIME CHANGE: IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

Retrieved on: 
Tuesday, November 29, 2022
Serenity, EST, Kidney, Food, Breast, Regulation of tobacco by the U.S. Food and Drug Administration, Annual report, Neoplasm, AME Publishing Company, Wellness, Surgeon, Risk, TASE, CE marking, Breast cancer, Freezing, Medical imaging

The scheduled time of the press release has been corrected to December 5, 2022 at 7:00 a.m. EST and the time of the conference call has been corrected to December 5, 2022 at 8:00 a.m. EST.

Key Points: 
  • The scheduled time of the press release has been corrected to December 5, 2022 at 7:00 a.m. EST and the time of the conference call has been corrected to December 5, 2022 at 8:00 a.m. EST.
  • Dr. Bednarski is a board certified general surgeon with a fellowship in aesthetic breast oncology, and she is known as an oncoplastic breast surgeon.
  • Its minimally invasive technology is a safe and effective alternative to hospital surgical tumorremoval that is easily performed in a relatively short procedure.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

Retrieved on: 
Monday, November 28, 2022
Serenity, EST, Kidney, Food, Breast, Regulation of tobacco by the U.S. Food and Drug Administration, Annual report, Neoplasm, AME Publishing Company, Wellness, Surgeon, Risk, TASE, CE marking, Freezing, Medical imaging

Dr. Bednarski is a board certified general surgeon with a fellowship in aesthetic breast oncology, and she is known as an oncoplastic breast surgeon.

Key Points: 
  • Dr. Bednarski is a board certified general surgeon with a fellowship in aesthetic breast oncology, and she is known as an oncoplastic breast surgeon.
  • Its minimally invasive technology is a safe and effective alternative to hospital surgical tumorremoval that is easily performed in a relatively short procedure.
  • Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.